Blue ribbon panel criticizes FDA and calls for reform of agency. Drug safety monitoring needs complete overhaul. A blue ribbon panel of scientists issued a highly critical report on Friday, on the health of the FDA. The report, requested by the FDA after VIOXX, a much used painkiller, was linked to heart attacks, concluded that the FDA has a number of serious problems which need immediate...